Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain

BSE407.00-1.05 (-0.26 %)

PREV CLOSE ( ) 408.05

OPEN PRICE ( ) 414.00

BID PRICE (QTY) 406.85 (29)

OFFER PRICE (QTY) 407.40 (74)

VOLUME 4553

TODAY'S LOW / HIGH ( )406.60 414.45

52 WK LOW / HIGH ( )235.6 581

NSE408.200.75 (+0.18 %)

PREV CLOSE( ) 407.45

OPEN PRICE ( ) 414.50

BID PRICE (QTY) 407.80 (1)

OFFER PRICE (QTY) 408.30 (1)

VOLUME 37529

TODAY'S LOW / HIGH( ) 405.00 414.50

52 WK LOW / HIGH ( )235.44 581.9

Chairman	Rajesh Jain
Managing Director	Rajesh Jain
Company Secretary	Vinod Goel
Joint Managing Director	Sandeep Jain
Non Executive Independent Director	Ambika Sharma Mukul Gupta Krishan Kumar Jalan Rajender Pal Singh Venkatesh Sarvasiddhi
Whole Time Director	Ankesh Jain Harshet Jain Sanjay Trehan
Non Independent & Non Executive Director	Narotam Kumar Juneja

Incorporation Year : 1984

Registered Office :

Address : Ambala - Chandigarh Highway,, Lalru,
Punjab-140501 .

Phone : 01762- 505900

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE